Pulse Biosciences Quarterly Investor Conference Call
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/12/2026
- Wall Street ends higher as SpaceX's market debut dominates
- SpaceX prices historic IPO at $135/share in largest ever new listing
- 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
- UBS cuts gold price forecasts on delayed Fed easing outlook
- Brent falls to lowest since March on expected peace deal
- NASDAQ adds five companies to NASDAQ-100 index in quarterly rebalance
- Adobe CFO Dan Durn to depart company in June 2026
- Oppenheimer Starts SpaceX (SPCX) at Outperform, PT $190, 'space infrastructure appears structurally advantaged'
- Pentagon reportedly locked down, hazmat teams responding
- Super Micro Computer establishes $1.25 billion stock sale agreement
Pulse Biosciences, Inc. (PLSE) Reports Q3 Loss of $0.64
October 30, 2018 4:40 PM EDTPulse Biosciences, Inc. (NASDAQ: PLSE) reported Q3 EPS of ($0.64).
Were pleased with the continued and significant progress weve made and are making towards bringing our NPS platform closer to commercialization, said Darrin Uecker, Pulse Biosciences President and Chief Executive Officer. Our data... More
